Narcolepsy.

Bassetti C.

Neurology Department, 
University Hospital (Inselspital), 
3010 Bern, Switzerland.
Curr Treat Options Neurol 1999 Sep;1(4):291-298

ABSTRACT

Narcolepsy is a disabling, chronic sleep-wake disorder that typically starts in a patient's second or third decade of life. Its key features are hypersomnia and cataplexy. Sleep paralysis, hallucinations, and disrupted sleep are nonspecific symptoms and are not always present. Disability relates primarily to sleepiness- related cognitive impairment, accidents, and psychosocial problems.  Treatment, which includes counseling, scheduled napping, and pharmacologic intervention, is effective for most patients.  Hypersomnia is best treated with such indirect sympathomimetics as mazindol, pemoline, methylphenidate, and amphetamine.  Modafinil may become the drug of choice because it has fewer side effects. Cataplexy, sleep paralysis, and hallucinations may be ameliorated by compounds, including clomipramine and imipramine, that suppress rapid eye movement (REM) sleep.  Regular follow-up visits enable the clinician to recognize uncommon but serious side effects (tolerance, substance abuse, psychosis, and hypertension) and additional sleep disturbances (sleep apnea, periodic limb movements in sleep, REM sleep behavior disorder), which can be specifically treated.

 1.   modafinil  is a potential treatment for fibromyalgia
 2.   modafinil  improves fatigue in patients with multiple sclerosis
 3.   modafinil  offers promise as an augmentation to antidepressants
 4.   modafinil  excessive sleepiness in Parkinson's disease
 5.   modafinil  excessive daytime sleepiness in Parkinson's disease
 6.   modafinil  may be useful for attention-deficit/hyperactivity disorder
 7.   modafinil  benefits cerebral palsy in an unknown way
 8.   modafinil  article
 9.   modafinil  amplification of cortical serotonin release
10.  modafinil  treatment of alcoholic organic brain syndrome
11.  modafinil  effect on melatonin, cortisol, and growth hormone
12.  modafinil  in obstructive sleep apnea-hypopnea syndrome
13.  modafinil  vs dextroamphetamine in treatment of adult ADHD
14.  modafinil  efficacy in narcolepsy
15.  modafinil  switching from narcolepsy drugs to modafinil
16.  modafinil  drug of choice for narcolepsy
17.  modafinil  dopaminergic transmission mediates CNS stimulants
18.  modafinil  for daytime sleepiness in sleep apnea
19.  modafinil  treatment of residual excessive daytime sleepiness
20.  modafinil  in the treatment of narcolepsy
21.  modafinil  and naps as counter measures in sleep deprivation
22.  modafinil  effect on narcolepsy
23.  modafinil  as a treatment for excessive daytime sleepiness
24.  modafinil  a narcolepsy study
25.  modafinil  use in a sleep deprivation experiment
26.  modafinil  for sustaining the alertness of helicopter pilots
27.  modafinil  the unique properties of a new stimulant
28.  modafinil  dosage and safety
29.  modafinil  in treatment of fatigue in multiple sclerosis
30.  modafinil  non-addictive potential of modafinil
31.  modafinil  successful treatment of hypersomnia & narcolepsy
32.  modafinil  physiological effects of modafinil in drug abusers
33.  modafinil  narcolepsy: symptoms and management
34.  modafinil  cognitive enhancing effects of modafinil

| Home | Order |
 

 

 

Hit Counter